DMEMEDS shared post via Reuters: U.S. court backs Shire in patent fight over Vyvanse drug

LONDON (Reuters) - Shire, which is seeking to defend itself after receiving a $46 billion approach from U.S. group AbbVie, said on Wednesday a U.S. court had endorsed its patents on top-selling hyperactivity drug Vyvanse. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/93TRpIxjQrw/story01.htm

Read More